首页> 美国卫生研究院文献>other >The Prevalence of Low Left Atrial Appendage Emptying Velocity and Thrombus in Patients Undergoing Catheter Ablation for Atrial Fibrillation on Uninterrupted Peri-procedural Warfarin Therapy
【2h】

The Prevalence of Low Left Atrial Appendage Emptying Velocity and Thrombus in Patients Undergoing Catheter Ablation for Atrial Fibrillation on Uninterrupted Peri-procedural Warfarin Therapy

机译:在不间断围手术期华法林治疗下行导管消融术治疗房颤的左下肢阑尾排空速度和血栓形成的患病率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Introduction: The 2012 HRS/EHRA/ECAS guidelines encourage pre-procedural transesophageal echocardiography (TEE) prior to ablation for atrial fibrillation (AF), but acknowledge a lack of consensus in patients maintained on therapeutic warfarin before, during and after the procedure. This is partly because the incidence of left atrial appendage (LAA) thrombus is so low, that it is hard to draw clear conclusion regarding the characteristics of patients who develop thrombus. We hypothesize that the presence of low LAA emptying velocities, which predisposes to thrombus, and/or thrombus itself can be predicted in patients undergoing ablation, based upon clinical characteristics and transthoracic echocardiography (TTE). >Methods: In this multicentre study, we undertook TTE and transesophageal echocardiograms (TEE) in 586 patients (age 59.9±0.4 years old, 64.5% male) undergoing catheter ablation for AF who were anticoagulated on warfarin (target international normalized ratio 2–3.5) for ≥3 consecutive weeks prior to procedure and maintained on warfarin for the procedure. >Results: Low peak LAA emptying velocities (<40cm/s) were identified in 111 (24.7%) patients and LAA thrombus was identified in 3 patients (0.5%) despite having therapeutic INRs. The 3 patients with thrombus had LAA emptying velocities of 23, 29 and 31 cm/s. None of the remaining patients had a peri-procedural stroke. Patients with peak LAA emptying velocities <40cm/s or thrombus on TEE had significantly (p<0.05) higher CHA2DS2-VASc scores (1.7± 0.1 v’s 1.4±0.1), and were more likely to have impaired LVSF (odds ratio [95% CI]: 2.66 [1.52-4.66]), a LA diameter >4.6cm on TTE (2.40 [2.13-5.41]), or persistent AF (2.60 [1.63-4.14]) compared to those with a higher LAA velocity without thrombus. >Conclusion: In patients on uninterrupted warfarin therapy, a CHA2DS2-VASc score ≥1 or LA diameter >4.6cm on TTE identifies 91.5% of those at risk of developing thrombus with LAA emptying velocity of <40 cm/s and 100% of those with thrombus in our cohort.
机译:>简介:2012年HRS / EHRA / ECAS指南鼓励在进行房颤(AF)消融之前进行术前经食管超声心动图(TEE),但承认在使用华法林之前对维持治疗的患者缺乏共识,手术期间和之后。部分原因是由于左心耳(LAA)血栓的发生率很低,因此很难就血栓形成患者的特征得出明确的结论。我们假设,根据临床特征和经胸超声心动图(TTE),可以对接受消融的患者预测存在易于形成血栓的低LAA排空速度和/或血栓本身。 >方法:在这项多中心研究中,我们对华法林抗凝的586例接受房颤消融的AF患者(年龄59.9±0.4岁,男64.5%)进行了TTE和经食道超声心动图(TEE)国际标准化比率2-3.5),在手术前连续3周≥3周,并在手术中维持华法林治疗。 >结果:尽管具有治疗性INR,但在111例(24.7%)患者中发现了低峰值LAA排空速度(<40cm / s),在3例患者(0.5%)中发现了LAA血栓。 3名血栓患者的LAA排空速度分别为23、29和31 cm / s。其余患者均无围手术期中风。 LAA排空峰值速度<40cm / s或TEE上的血栓形成的患者,CHA2DS2-VASc评分(1.7±0.1 v's 1.4±0.1)显着较高(p <0.05),并且更有可能出现LVSF受损(几率[95% CI]:2.66 [1.52-4.66]),与没有血栓的LAA速度较高的患者相比,TTE的LA直径> 4.6cm(2.40 [2.13-5.41])或持续性AF(2.60 [1.63-4.14])。 >结论:在不间断使用华法林治疗的患者中,TTE的CHA2DS2-VASc得分≥1或LA直径> 4.6cm的患者中有91.5%的患者发生LAA排空速度<40 cm / s和我们队列中100%的血栓患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号